Wolverine Trading
CRDF icon

Wolverine Trading’s Cardiff Oncology CRDF Stock Holding History

Wolverine Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$52.8K Buy
25,400
+5,400
+27% +$14.9K ﹤0.01% 5400
2025
Q2 		$63K Sell
20,000
-1,600
-7% -$4.88K ﹤0.01% 4290
2025
Q1 		$71.1K Sell
21,600
-16,400
-43% -$64.9K ﹤0.01% 4320
2024
Q4 		$162K Buy
38,000
+9,900
+35% +$30.9K ﹤0.01% 4641
2024
Q3 		$77.8K Buy
28,100
+14,800
+111% +$35K ﹤0.01% 4420
2024
Q2 		$29.5K Buy
+13,300
New +$50.1K ﹤0.01% 4289
2022
Q4 		– Sell
-15,900
Closed -$24K – 4141
2022
Q3 		$24K Buy
+15,900
New +$38.3K ﹤0.01% 4340
2017
Q2 		– Sell
-240
Closed -$20K – 4344
2017
Q1 		$20K Buy
240
+7
+3% +$951 ﹤0.01% 4095
2016
Q4 		$35K Buy
+233
New +$54.4K ﹤0.01% 4260

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wolverine Trading's CRDF Position: Q3 2025 in Review

Wolverine Trading sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 14,573 shares — an estimated $40.3K sold.

Wolverine Trading first reported a position in CRDF in Q4 2016 and held it in 7 quarters. The position peaked at $104K in Q4 2024. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Wolverine Trading reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 14,573 Cardiff Oncology shares in Q3 2025, an estimated $40.3K.
  • Wolverine Trading first reported a position in Cardiff Oncology in Q4 2016 and held it in 7 quarters.
  • Wolverine Trading's Cardiff Oncology position peaked at $104K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.